A detailed history of Victory Capital Management Inc transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 15,014 shares of MCRB stock, worth $10,810. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,014
Previous 13,135 14.31%
Holding current value
$10,810
Previous $18,000 38.89%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

BUY
$0.75 - $1.56 $1,409 - $2,931
1,879 Added 14.31%
15,014 $11,000
Q4 2023

Feb 05, 2024

BUY
$0.93 - $2.15 $2,388 - $5,521
2,568 Added 24.3%
13,135 $18,000
Q3 2023

Nov 06, 2023

BUY
$2.33 - $5.07 $782 - $1,703
336 Added 3.28%
10,567 $25,000
Q2 2023

Jul 27, 2023

SELL
$4.67 - $6.55 $1,111 - $1,558
-238 Reduced 2.27%
10,231 $49,000
Q1 2023

May 02, 2023

SELL
$4.95 - $6.09 $455 - $560
-92 Reduced 0.87%
10,469 $59,000
Q4 2022

Feb 09, 2023

SELL
$5.09 - $9.05 $20 - $36
-4 Reduced 0.04%
10,561 $59,000
Q3 2022

Nov 02, 2022

BUY
$3.5 - $7.2 $36,977 - $76,068
10,565 New
10,565 $68,000
Q3 2021

Nov 02, 2021

SELL
$5.46 - $22.6 $86,251 - $357,012
-15,797 Closed
0 $0
Q2 2021

Aug 03, 2021

SELL
$18.46 - $24.36 $128,186 - $169,155
-6,944 Reduced 30.54%
15,797 $377,000
Q1 2021

May 04, 2021

SELL
$17.66 - $28.92 $684,589 - $1.12 Million
-38,765 Reduced 63.03%
22,741 $468,000
Q4 2020

Feb 01, 2021

BUY
$23.25 - $37.73 $393,064 - $637,863
16,906 Added 37.91%
61,506 $1.51 Million
Q3 2020

Nov 09, 2020

BUY
$3.74 - $28.74 $166,804 - $1.28 Million
44,600 New
44,600 $1.26 Million
Q2 2020

Aug 07, 2020

SELL
$3.04 - $6.2 $14,962 - $30,516
-4,922 Closed
0 $0
Q1 2020

May 04, 2020

BUY
$2.64 - $3.82 $224 - $324
85 Added 1.76%
4,922 $18,000
Q4 2019

Feb 04, 2020

SELL
$2.99 - $4.42 $5,965 - $8,817
-1,995 Reduced 29.2%
4,837 $16,000
Q3 2019

Nov 12, 2019

BUY
$2.29 - $4.16 $15,645 - $28,421
6,832 New
6,832 $27,000

Others Institutions Holding MCRB

About Seres Therapeutics, Inc.


  • Ticker MCRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,072,000
  • Market Cap $89.3M
  • Description
  • Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...
More about MCRB
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.